Hatakawa Y, Takeuchi Y, Lee SH, Oe T. Tyrosine modifications of insulin-degrading enzyme enable favorable control of substrate specificity for both Alzheimer's disease and type-2 diabetes mellitus. Bioorg Chem. 2024 Dec;153:107916. Epub 2024 Oct 24 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.